A citation-based method for searching scientific literature

Alessandro Orsini, Angelo Valetto, Veronica Bertini, Mariagrazia Esposito, Niccolò Carli, Berge A Minassian, Alice Bonuccelli, Diego Peroni, Roberto Michelucci, Pasquale Striano. Seizure 2019
Times Cited: 19







List of co-cited articles
69 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The genetic landscape of the epileptic encephalopathies of infancy and childhood.
Amy McTague, Katherine B Howell, J Helen Cross, Manju A Kurian, Ingrid E Scheffer. Lancet Neurol 2016
258
21

Progressive myoclonic epilepsies: definitive and still undetermined causes.
Silvana Franceschetti, Roberto Michelucci, Laura Canafoglia, Pasquale Striano, Antonio Gambardella, Adriana Magaudda, Paolo Tinuper, Angela La Neve, Edoardo Ferlazzo, Giuseppe Gobbi,[...]. Neurology 2014
56
21

Lafora disease - from pathogenesis to treatment strategies.
Felix Nitschke, Saija J Ahonen, Silvia Nitschke, Sharmistha Mitra, Berge A Minassian. Nat Rev Neurol 2018
52
21

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
Jacqueline A French, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, Dennis J Dlugos, Noah Berkowitz,[...]. Lancet 2016
302
15

Early and effective treatment of KCNQ2 encephalopathy.
Tiziana Pisano, Adam L Numis, Sinéad B Heavin, Sarah Weckhuysen, Marco Angriman, Arvid Suls, Barbara Podesta, Ronald L Thibert, Kevin A Shapiro, Renzo Guerrini,[...]. Epilepsia 2015
111
15

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Orrin Devinsky, J Helen Cross, Linda Laux, Eric Marsh, Ian Miller, Rima Nabbout, Ingrid E Scheffer, Elizabeth A Thiele, Stephen Wright. N Engl J Med 2017
594
15

Managing Lafora body disease with vagal nerve stimulation.
Mohamad A Mikati, Faysal Tabbara. Epileptic Disord 2017
8
37

Study of Intraventricular Cerliponase Alfa for CLN2 Disease.
Angela Schulz, Temitayo Ajayi, Nicola Specchio, Emily de Los Reyes, Paul Gissen, Douglas Ballon, Jonathan P Dyke, Heather Cahan, Peter Slasor, David Jacoby,[...]. N Engl J Med 2018
170
15

Progressive Myoclonus Epilepsies.
Reetta Kälviäinen. Semin Neurol 2015
34
15

Unverricht-Lundborg disease.
Arielle Crespel, Edoardo Ferlazzo, Silvana Franceschetti, Pierre Genton, Riadh Gouider, Reetta Kälviäinen, Miikka Korja, Maria K Lehtinen, Esa Mervaala, Michele Simonato,[...]. Epileptic Disord 2016
22
15

Progressive myoclonic epilepsy.
Mary L Zupanc, Benjamin Legros. Cerebellum 2004
20
15

Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.
M Kathryn Brewer, Annette Uittenbogaard, Grant L Austin, Dyann M Segvich, Anna DePaoli-Roach, Peter J Roach, John J McCarthy, Zoe R Simmons, Jason A Brandon, Zhengqiu Zhou,[...]. Cell Metab 2019
32
15

Lafora disease.
Julie Turnbull, Erica Tiberia, Pasquale Striano, Pierre Genton, Stirling Carpenter, Cameron A Ackerley, Berge A Minassian. Epileptic Disord 2016
69
15

GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.
Tyler Mark Pierson, Hongjie Yuan, Eric D Marsh, Karin Fuentes-Fajardo, David R Adams, Thomas Markello, Gretchen Golas, Dimitre R Simeonov, Conisha Holloman, Anel Tankovic,[...]. Ann Clin Transl Neurol 2014
143
10

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Orrin Devinsky, Anup D Patel, J Helen Cross, Vicente Villanueva, Elaine C Wirrell, Michael Privitera, Sam M Greenwood, Claire Roberts, Daniel Checketts, Kevan E VanLandingham,[...]. N Engl J Med 2018
325
10

Lack of response to quinidine in KCNT1-related neonatal epilepsy.
Adam L Numis, Umesh Nair, Anita N Datta, Tristan T Sands, Michael S Oldham, Akash Patel, Melody Li, Elena Gazina, Steven Petrou, Maria Roberta Cilio. Epilepsia 2018
27
10

Precision therapy for epilepsy due to KCNT1 mutations: A randomized trial of oral quinidine.
Saul A Mullen, Patrick W Carney, Annie Roten, Michael Ching, Paul A Lightfoot, Leonid Churilov, Umesh Nair, Melody Li, Samuel F Berkovic, Steven Petrou,[...]. Neurology 2018
51
10

Depdc5 knockdown causes mTOR-dependent motor hyperactivity in zebrafish.
Hortense de Calbiac, Adriana Dabacan, Elise Marsan, Hervé Tostivint, Gabrielle Devienne, Saeko Ishida, Eric Leguern, Stéphanie Baulac, Raul C Muresan, Edor Kabashi,[...]. Ann Clin Transl Neurol 2018
20
10

Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
Jacqueline A French, Gregory L Krauss, Robert T Wechsler, Xue-Feng Wang, Bree DiVentura, Christian Brandt, Eugen Trinka, Terence J O'Brien, Antonio Laurenza, Anna Patten,[...]. Neurology 2015
175
10

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.
Ingrid E Scheffer, Samuel Berkovic, Giuseppe Capovilla, Mary B Connolly, Jacqueline French, Laura Guilhoto, Edouard Hirsch, Satish Jain, Gary W Mathern, Solomon L Moshé,[...]. Epilepsia 2017
10

Current understanding and neurobiology of epileptic encephalopathies.
Stéphane Auvin, Maria Roberta Cilio, Annamaria Vezzani. Neurobiol Dis 2016
52
10

Rapid and safe response to low-dose carbamazepine in neonatal epilepsy.
Tristan T Sands, Martina Balestri, Giulia Bellini, Sarah B Mulkey, Olivier Danhaive, Eliza Hayes Bakken, Maurizio Taglialatela, Michael S Oldham, Federico Vigevano, Gregory L Holmes,[...]. Epilepsia 2016
48
10

Ineffective quinidine therapy in early onset epileptic encephalopathy with KCNT1 mutation.
Pin Fee Chong, Ryoko Nakamura, Hirotomo Saitsu, Naomichi Matsumoto, Ryutaro Kira. Ann Neurol 2016
46
10

Quinidine in the treatment of KCNT1-positive epilepsies.
Mohamad A Mikati, Yong-Hui Jiang, Michael Carboni, Vandana Shashi, Slave Petrovski, Rebecca Spillmann, Carol J Milligan, Melody Li, Annette Grefe, Allyn McConkie,[...]. Ann Neurol 2015
102
10

Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Markus Wolff, Katrine M Johannesen, Ulrike B S Hedrich, Silvia Masnada, Guido Rubboli, Elena Gardella, Gaetan Lesca, Dorothée Ville, Mathieu Milh, Laurent Villard,[...]. Brain 2017
212
10

A Review of the New Antiepileptic Drugs for Focal-Onset Seizures in Pediatrics: Role of Extrapolation.
Alexis Arzimanoglou, O'Neill D'Cruz, Douglas Nordli, Shlomo Shinnar, Gregory L Holmes. Paediatr Drugs 2018
13
15

Targeted treatment of migrating partial seizures of infancy with quinidine.
David Bearden, Alanna Strong, Jessica Ehnot, Marissa DiGiovine, Dennis Dlugos, Ethan M Goldberg. Ann Neurol 2014
125
10

Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.
Ronit M Pressler, Geraldine B Boylan, Neil Marlow, Mats Blennow, Catherine Chiron, J Helen Cross, Linda S de Vries, Boubou Hallberg, Lena Hellström-Westas, Vincent Jullien,[...]. Lancet Neurol 2015
144
10

GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Brice Mullier, Christian Wolff, Zara Amanda Sands, Philippe Ghisdal, Pierandrea Muglia, Rafal Marian Kaminski, Véronique Marie André. Neuropharmacology 2017
27
10

Mitochondrial disease and epilepsy.
Shamima Rahman. Dev Med Child Neurol 2012
84
10

Recent advances in epilepsy genetics.
Alessandro Orsini, Federico Zara, Pasquale Striano. Neurosci Lett 2018
41
10

Update on pharmacotherapy of myoclonic seizures.
Pasquale Striano, Vincenzo Belcastro. Expert Opin Pharmacother 2017
8
25

Tackling Epilepsy With High-definition Precision Medicine: A Review.
Hugh Kearney, Susan Byrne, Gianpiero L Cavalleri, Norman Delanty. JAMA Neurol 2019
24
10

A pilot study of a ketogenic diet in patients with Lafora body disease.
Simonetta Cardinali, Laura Canafoglia, Simona Bertoli, Silvana Franceschetti, Giovanni Lanzi, Anna Tagliabue, Pierangelo Veggiotti. Epilepsy Res 2006
43
10

Super refractory status epilepticus in Lafora disease interrupted by vagus nerve stimulation: A case report.
B Mostacci, F Bisulli, L Muccioli, I Minardi, M Bandini, L Licchetta, M Zucchelli, C Leta, R Michelucci, M Zanello,[...]. Brain Stimul 2019
3
66

Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy.
Liliana Matos, Ana Joana Duarte, Diogo Ribeiro, João Chaves, Olga Amaral, Sandra Alves. Genes (Basel) 2018
7
28


Typical progression of myoclonic epilepsy of the Lafora type: a case report.
Pasquale Striano, Federico Zara, Julie Turnbull, Jean-Marie Girard, Cameron A Ackerley, Mariarosaria Cervasio, Gaetano De Rosa, Maria Laura Del Basso-De Caro, Salvatore Striano, Berge A Minassian. Nat Clin Pract Neurol 2008
36
10

Brain inflammation is accompanied by peripheral inflammation in Cstb -/- mice, a model for progressive myoclonus epilepsy.
Olesya Okuneva, Zhilin Li, Inken Körber, Saara Tegelberg, Tarja Joensuu, Li Tian, Anna-Elina Lehesjoki. J Neuroinflammation 2016
17
11

Vagus nerve stimulation in Lafora body disease.
Sanja Hajnsek, Zeljka Petelin Gadze, Fran Borovecki, Sibila Nankovic, Goran Mrak, Kristina Gotovac, Vlatko Sulentic, Ivana Kovacevic, Andreja Bujan Kovac. Epilepsy Behav Case Rep 2013
10
20

Gene expression alterations in the cerebellum and granule neurons of Cstb(-/-) mouse are associated with early synaptic changes and inflammation.
Tarja Joensuu, Saara Tegelberg, Eva Reinmaa, Mikael Segerstråle, Paula Hakala, Heidi Pehkonen, Esa R Korpi, Jaana Tyynelä, Tomi Taira, Iiris Hovatta,[...]. PLoS One 2014
20
10

Laforin, the most common protein mutated in Lafora disease, regulates autophagy.
Carmen Aguado, Sovan Sarkar, Viktor I Korolchuk, Olga Criado, Santiago Vernia, Patricia Boya, Pascual Sanz, Santiago Rodríguez de Córdoba, Erwin Knecht, David C Rubinsztein. Hum Mol Genet 2010
133
10

Innate Immune Response in Brain, NF-Kappa B Signaling and Cystatins.
Nataša Kopitar-Jerala. Front Mol Neurosci 2015
65
10

Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects.
Amre Shahwan, Michael Farrell, Norman Delanty. Lancet Neurol 2005
132
10

Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age.
Marcos Lahuerta, Daymé Gonzalez, Carmen Aguado, Alihamze Fathinajafabadi, José Luis García-Giménez, Mireia Moreno-Estellés, Carlos Romá-Mateo, Erwin Knecht, Federico V Pallardó, Pascual Sanz. Mol Neurobiol 2020
19
10

Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.
Irene López-González, Rosa Viana, Pascual Sanz, Isidre Ferrer. Mol Neurobiol 2017
27
10

Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
Lotta Parviainen, Sybille Dihanich, Greg W Anderson, Andrew M Wong, Helen R Brooks, Rosella Abeti, Payam Rezaie, Giovanna Lalli, Simon Pope, Simon J Heales,[...]. Acta Neuropathol Commun 2017
34
10


Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy.
Annamaria Vezzani, Silvia Balosso, Teresa Ravizza. Nat Rev Neurol 2019
174
10

Degradation of altered mitochondria by autophagy is impaired in Lafora disease.
Marcos Lahuerta, Carmen Aguado, Pablo Sánchez-Martín, Pascual Sanz, Erwin Knecht. FEBS J 2018
16
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.